France· FR:65621001
SULFATE DE MAGNESIUM RENAUDIN 10 %, solution injectable (IV)
A medicinal product containing sulfate de magnésium heptahydraté, registered in France by LABORATOIRE RENAUDIN.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE DE MAGNÉSIUM HEPTAHYDRATÉ
- Manufacturer
- LABORATOIRE RENAUDIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093619220110 ampoule(s) en verre de 10 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfate de magnésium heptahydraté in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAquaDerm Hydrous ointmentImpectron Ltd
- NetherlandsMagnesiumsulfaat Eureco-Pharma 100 mg/ml, oplossing voor injectieEureco-Pharma B.V.
- PolandInj. Magnesii Sulfurici 20% PolpharmaZakłady Farmaceutyczne POLPHARMA S.A.
- SpainSULFATO DE MAGNESIO ALTAN 150 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFGAltan Pharmaceuticals Sa
- CanadaMAGNESIUM SULFATE IN WATER FOR INJECTIONBAXTER CORPORATION
- United States50% MAGNESIUM SULFATEHF Acquisition Co. LLC, DBA Health First
- FinlandAddex-MagnesiumsulfaattiFresenius Kabi AB
- Japan硫酸マグネシウム水和物
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Denmark · Magnesiumsulfat Sad
- United Kingdom (Northern Ireland) · Magnesium Sulphate Phoenix Labs
- Greece · Magnesium Sulfate Ariti
- Ireland · Magnesium Sulfate Foran Healthcare
- Netherlands · Magnesiiumsulfaat Teva, Magnesiumsulfaat Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b12f3229-7b04-4724-8b89-1e72b03e91c0 GET /v1/drugs/b12f3229-7b04-4724-8b89-1e72b03e91c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65621001",
"date_amm": "2003-05-05",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULFATE DE MAGNÉSIUM HEPTAHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulfate de magnésium heptahydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.